Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Several 7TM receptors have been cloned but theirendogenous ligands are unknown; these have been termed orphan receptors. However, recent research has identified certain pharmacological targets that could be investigated to find, for example, new potential cannabinoid receptors or channels [, , ]. GPR18 [, ], GPR55 [, ], GPR119 []show little structural similarity to CB1 and CB2 receptors, but they respond to endogenous agents analogous to the endogenous cannabinoid ligands, as well as some natural/synthetic cannabinoid receptor ligands []. However, because they do not fulfill all of the cannabinoid receptor criteria defined by IUPHAR, the classification of these proteins remains a contentious issue due to conflicting pharmacological results. As a result, they remain classified as putative endogenous agonists by IUPHAR [].This entry represents G protein-coupled receptor 55. It is thought to play a role in bone physiology by regulating osteoclast number and function []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Whyte LS |
Year: |
2009 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. |
Volume: |
106 |
Issue: |
38 |
Pages: |
16511-6 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Publication |
First Author: |
Carey LM |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice. |
Volume: |
7 |
Issue: |
1 |
Pages: |
944 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cherif H |
Year: |
2015 |
Journal: |
eNeuro |
Title: |
Role of GPR55 during Axon Growth and Target Innervation. |
Volume: |
2 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Korchynska S |
Year: |
2019 |
Journal: |
JCI Insight |
Title: |
GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation. |
Volume: |
4 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ryberg E |
Year: |
2007 |
Journal: |
Br J Pharmacol |
Title: |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
Volume: |
152 |
Issue: |
7 |
Pages: |
1092-101 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pietr M |
Year: |
2009 |
Journal: |
FEBS Lett |
Title: |
Differential changes in GPR55 during microglial cell activation. |
Volume: |
583 |
Issue: |
12 |
Pages: |
2071-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hill JD |
Year: |
2018 |
Journal: |
Br J Pharmacol |
Title: |
Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. |
Volume: |
175 |
Issue: |
16 |
Pages: |
3407-3421 |
|
•
•
•
•
•
|
Publication |
First Author: |
Romero-Zerbo SY |
Year: |
2011 |
Journal: |
J Endocrinol |
Title: |
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. |
Volume: |
211 |
Issue: |
2 |
Pages: |
177-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hurst K |
Year: |
2017 |
Journal: |
Hippocampus |
Title: |
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. |
Volume: |
27 |
Issue: |
9 |
Pages: |
985-998 |
|
•
•
•
•
•
|
Publication |
First Author: |
Puhl SL |
Year: |
2021 |
Journal: |
Sci Rep |
Title: |
Haematopoietic and cardiac GPR55 synchronize post-myocardial infarction remodelling. |
Volume: |
11 |
Issue: |
1 |
Pages: |
14385 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stančić A |
Year: |
2015 |
Journal: |
Neurogastroenterol Motil |
Title: |
The GPR55 antagonist CID16020046 protects against intestinal inflammation. |
Volume: |
27 |
Issue: |
10 |
Pages: |
1432-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hill JD |
Year: |
2019 |
Journal: |
Brain Behav Immun |
Title: |
Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation. |
Volume: |
76 |
|
Pages: |
165-181 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li K |
Year: |
2013 |
Journal: |
Neuropharmacology |
Title: |
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. |
Volume: |
71 |
|
Pages: |
255-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sylantyev S |
Year: |
2013 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. |
Volume: |
110 |
Issue: |
13 |
Pages: |
5193-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pérez-Gómez E |
Year: |
2013 |
Journal: |
Oncogene |
Title: |
The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. |
Volume: |
32 |
Issue: |
20 |
Pages: |
2534-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schopohl B |
Year: |
2025 |
Journal: |
Br J Pharmacol |
Title: |
Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice. |
Volume: |
182 |
Issue: |
3 |
Pages: |
670-691 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ono T |
Year: |
2023 |
Journal: |
Brain Behav Immun |
Title: |
GPR55 contributes to neutrophil recruitment and mechanical pain induction after spinal cord compression in mice. |
Volume: |
110 |
|
Pages: |
276-287 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lipina C |
Year: |
2019 |
Journal: |
FASEB J |
Title: |
GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues. |
Volume: |
33 |
Issue: |
1 |
Pages: |
1299-1312 |
|
•
•
•
•
•
|
Publication |
First Author: |
Walsh SK |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses. |
Volume: |
9 |
Issue: |
9 |
Pages: |
e108999 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bjursell M |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation. |
Volume: |
11 |
Issue: |
12 |
Pages: |
e0167965 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gajghate S |
Year: |
2024 |
Journal: |
Cells |
Title: |
GPR55 Inactivation Diminishes Splenic Responses and Improves Neurological Outcomes in the Mouse Ischemia/Reperfusion Stroke Model. |
Volume: |
13 |
Issue: |
3 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ferro R |
Year: |
2018 |
Journal: |
Oncogene |
Title: |
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. |
Volume: |
37 |
Issue: |
49 |
Pages: |
6368-6382 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Publication |
First Author: |
Guillamat-Prats R |
Year: |
2022 |
Journal: |
Nat Cardiovasc Res |
Title: |
GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation. |
Volume: |
1 |
|
Pages: |
1056-1071 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hasenoehrl C |
Year: |
2018 |
Journal: |
Int J Cancer |
Title: |
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1. |
Volume: |
142 |
Issue: |
1 |
Pages: |
121-132 |
|
•
•
•
•
•
|
Publication |
First Author: |
Johns DG |
Year: |
2007 |
Journal: |
Br J Pharmacol |
Title: |
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. |
Volume: |
152 |
Issue: |
5 |
Pages: |
825-31 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689419 |
|
Stage: |
TS19 |
Assay Id: |
MGI:6190430 |
Age: |
embryonic day 11.5 |
|
|
Specimen Label: |
Table S2 - E11.5 - Gpr55 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689421 |
|
Stage: |
TS21 |
Assay Id: |
MGI:6190430 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
Table S2 - E13.5 - Gpr55 |
Detected: |
false |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689424 |
|
Stage: |
TS24 |
Assay Id: |
MGI:6190430 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
Table S2 - E15.5 - Gpr55 |
Detected: |
false |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689426 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6190430 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
Table S2 - E18.5 - Gpr55 |
Detected: |
false |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190430 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - Gpr55 |
Detected: |
false |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190430 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - Gpr55 |
Detected: |
false |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6174326 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190430 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - Gpr55 |
Detected: |
false |
Specimen Num: |
7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anderson LL |
Year: |
2023 |
Journal: |
PLoS One |
Title: |
Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome. |
Volume: |
18 |
Issue: |
1 |
Pages: |
e0280842 |
|
•
•
•
•
•
|
Publication |
First Author: |
McHugh D |
Year: |
2012 |
Journal: |
Br J Pharmacol |
Title: |
Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. |
Volume: |
165 |
Issue: |
8 |
Pages: |
2414-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
McHugh D |
Year: |
2010 |
Journal: |
BMC Neurosci |
Title: |
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. |
Volume: |
11 |
|
Pages: |
44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pertwee RG |
Year: |
2007 |
Journal: |
Br J Pharmacol |
Title: |
GPR55: a new member of the cannabinoid receptor clan? |
Volume: |
152 |
Issue: |
7 |
Pages: |
984-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Izzo AA |
Year: |
2010 |
Journal: |
Pharmacol Ther |
Title: |
Cannabinoids and the gut: new developments and emerging concepts. |
Volume: |
126 |
Issue: |
1 |
Pages: |
21-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brown AJ |
Year: |
2007 |
Journal: |
Br J Pharmacol |
Title: |
Novel cannabinoid receptors. |
Volume: |
152 |
Issue: |
5 |
Pages: |
567-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pertwee RG |
Year: |
2010 |
Journal: |
Pharmacol Rev |
Title: |
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. |
Volume: |
62 |
Issue: |
4 |
Pages: |
588-631 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
327
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
327
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
327
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu CS |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. |
Volume: |
8 |
Issue: |
4 |
Pages: |
e60314 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ruz-Maldonado I |
Year: |
2020 |
Journal: |
Cell Mol Life Sci |
Title: |
The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling. |
Volume: |
77 |
Issue: |
22 |
Pages: |
4709-4723 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meadows A |
Year: |
2016 |
Journal: |
Int J Obes (Lond) |
Title: |
Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. |
Volume: |
40 |
Issue: |
3 |
Pages: |
417-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hawken ER |
Year: |
2019 |
Journal: |
Neuropsychopharmacology |
Title: |
A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis. |
Volume: |
44 |
Issue: |
7 |
Pages: |
1274-1283 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schicho R |
Year: |
2011 |
Journal: |
Inflamm Bowel Dis |
Title: |
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. |
Volume: |
17 |
Issue: |
8 |
Pages: |
1651-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Austrich-Olivares A |
Year: |
2022 |
Journal: |
Pharmaceuticals (Basel) |
Title: |
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice. |
Volume: |
15 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Guy AT |
Year: |
2015 |
Journal: |
Science |
Title: |
NEURONAL DEVELOPMENT. Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord. |
Volume: |
349 |
Issue: |
6251 |
Pages: |
974-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sisay S |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. |
Volume: |
8 |
Issue: |
10 |
Pages: |
e76907 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rosenberg EC |
Year: |
2023 |
Journal: |
Neuron |
Title: |
Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity. |
Volume: |
111 |
Issue: |
8 |
Pages: |
1282-1300.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhai K |
Year: |
2020 |
Journal: |
Eur J Immunol |
Title: |
IL-10 promotes malignant pleural effusion by regulating TH 1 response via an miR-7116-5p/GPR55/ERK pathway in mice. |
Volume: |
50 |
Issue: |
11 |
Pages: |
1798-1809 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grill M |
Year: |
2019 |
Journal: |
Histochem Cell Biol |
Title: |
Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. |
Volume: |
151 |
Issue: |
1 |
Pages: |
5-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu CS |
Year: |
2010 |
Journal: |
Eur J Neurosci |
Title: |
Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. |
Volume: |
32 |
Issue: |
5 |
Pages: |
693-706 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Toomey NL |
Year: |
2001 |
Journal: |
Oncogene |
Title: |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. |
Volume: |
20 |
Issue: |
48 |
Pages: |
7029-40 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754422 |
|
Stage: |
TS22 |
Assay Id: |
MGI:6388719 |
Age: |
embryonic day 14.0-15.0 |
Image: |
2 |
|
Specimen Label: |
E14/15 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754423 |
|
Stage: |
TS23 |
Assay Id: |
MGI:6388719 |
Age: |
embryonic day 14.0-15.0 |
Image: |
2 |
|
Specimen Label: |
E14/15 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754424 |
|
Stage: |
TS24 |
Assay Id: |
MGI:6388719 |
Age: |
embryonic day 16.0-17.0 |
Image: |
2 |
|
Specimen Label: |
E16/17 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754425 |
|
Stage: |
TS25 |
Assay Id: |
MGI:6388719 |
Age: |
embryonic day 16.0-17.0 |
Image: |
2 |
|
Specimen Label: |
E16/17 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754426 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6388719 |
Age: |
embryonic day 18.0-19.0 |
Image: |
2 |
|
Specimen Label: |
E18/19 |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754427 |
|
Stage: |
TS27 |
Assay Id: |
MGI:6388719 |
Age: |
postnatal day 1 |
Image: |
2 |
|
Specimen Label: |
P1 |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1754427 |
|
Stage: |
TS27 |
Assay Id: |
MGI:6388719 |
Age: |
postnatal day 3 |
Image: |
2 |
|
Specimen Label: |
P3 |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716823 |
|
Stage: |
TS23 |
Assay Id: |
MGI:6388718 |
Age: |
embryonic day 14.0-15.0 |
Image: |
2 |
|
Specimen Label: |
E14/15 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716822 |
|
Stage: |
TS22 |
Assay Id: |
MGI:6388718 |
Age: |
embryonic day 14.0-15.0 |
Image: |
2 |
|
Specimen Label: |
E14/15 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716825 |
|
Stage: |
TS25 |
Assay Id: |
MGI:6388718 |
Age: |
embryonic day 16.0-17.0 |
Image: |
2 |
|
Specimen Label: |
E16/17 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716824 |
|
Stage: |
TS24 |
Assay Id: |
MGI:6388718 |
Age: |
embryonic day 16.0-17.0 |
Image: |
2 |
|
Specimen Label: |
E16/17 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716826 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6388718 |
Age: |
embryonic day 18.0-19.0 |
Image: |
2 |
|
Specimen Label: |
E18/19 |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716827 |
|
Stage: |
TS27 |
Assay Id: |
MGI:6388718 |
Age: |
postnatal day 1 |
Image: |
2 |
|
Specimen Label: |
P1 |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388712 |
Assay Type: |
Western blot |
Annotation Date: |
2020-02-05 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716827 |
|
Stage: |
TS27 |
Assay Id: |
MGI:6388718 |
Age: |
postnatal day 3 |
Image: |
2 |
|
Specimen Label: |
P3 |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|